The DES Center

Filter Your Results




Medinol’s JNIR Study of EluNIR DES Approved in Japan

November 7, 2016 -- Medinol, Ltd. announced the receipt of a Clinical Trial Notification from Japan’s Pharmaceutical and Medical Devices Agency to initiate its…

Abbott Vascular's Absorb Bioresorbable Vascular Scaffold Approved in Japan

November 7, 2016 -- Abbott Vascular announced Japan’s Ministry of Health, Labor, and Welfare has approved the company’s Absorb bioresorbable coronary stent. Sold c…

Five-Year DESSOLVE Data Presented for Micell Technologies’ MiStent

November 7, 2016 -- Micell Technologies, Inc. announced 5-year clinical safety and efficacy results from the DESSOLVE I and DESSOLVE II trials of the company’s MiSt…

PRISON IV Trial Evaluates Biotronik’s Osiro Biodegradable SES to Treat CTOs

November 2, 2016 -- The randomized multicenter PRISON IV trial evaluated Biotronik’s hybrid, ultra-thin strut Osiro sirolimus-eluting stent (SES) with a biodeg…

TRANSFORM-OCT Evaluates Strut Coverage and Neoatherosclerosis in Bioresorbable Versus Durable Polymer DES

November 2, 2016 -- Results from TRANSFORM-OCT, a prospective, randomized trial that used optical coherence tomography (OCT) to evaluate strut coverage and neoatherosclerosis …

Three-year EXCEL Data Evaluate Abbott Vascular’s EES in Left Main CAD

October 31, 2016 -- Three-year results from the EXCEL trial were presented at TCT 2016, the 28th annual Transcatheter Cardiovascular Therapeutics scientific symposium in Washi…

First-in-Human REVELUTION Data Presented for Medtronic’s Drug-Filled Stent

October 31, 2016 -- The first-in-human REVELUTION study of Medtronic plc’s new polymer-free, drug-filled stent (DFS) indicated noninferior in-stent late lumen loss at 9-…

FANTOM II Results Presented for Reva Medical’s Fantom Bioresorbable Vascular Scaffold

October 31, 2016 -- The FANTOM II study was presented during the First Report Investigations presentations on bioresorbable stent technologies at TCT 2016, the 28th annua…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.